Presentations and posters will be made available here.
Upcoming events
H.C. Wainwright Global Investment Conference
24 May, 2022
Past events
MRx0518 and Keytruda Phase I/II Interim Results RCC Conference Call & Webcast
23 March, 2022
North of Scotland Parkinson’s Research Interest Group (NoSPRIG) and Dundee Research Interest Group (DRIG), Meet the Scientists @ 4D Pharma
31 January, 2022
Virtual KOL Event: MRx-4DP0004 Phase I/II Part A Results
27 January, 2022
Event will review the results of Part A of the Phase I/II trial of MRx-4DP0004 for the treatment of asthma, featuring presentations from 4D pharma management and Prof. Chris Brightling, National Institute for Health Research (NIHR) Senior Investigator and Clinical Professor in Respiratory Medicine, Department of Respiratory Sciences, University of Leicester, UK
Ladenburg Thalmann & Co. R&D; Showcase - MRx0518
26 May, 2021
4D pharma CSO Dr Alex Stevenson is joined by Dr Joaquim Bellmunt, Associate Professor at Harvard Medical School, Director of Bladder Cancer Program at Beth Israel Deaconess Medical Center and former Director of the Bladder Cancer Center at Dana-Farber Cancer Institute
Digestive Disease Week 2021
21-23 May, 2021
Click here for webcast or download a copy of the presentation here
